SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-182525
Filing Date
2014-05-05
Accepted
2014-05-05 16:26:35
Documents
2
Period of Report
2014-05-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d721196d8k.htm 8-K 14652
2 EX-99.1 d721196dex991.htm EX-99.1 43905
  Complete submission text file 0001193125-14-182525.txt   59771
Mailing Address 3960 BROADWAY NEW YORK NY 10032
Business Address 3960 BROADWAY NEW YORK NY 10032 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36274 | Film No.: 14813797
SIC: 2834 Pharmaceutical Preparations